Top Industry News
- SFDA- Drug File Validation Criteria
- Malaysia Provides Guidance on Regulatory Control of Atypical APIs
- FDA Proposes Additional Class II Devices to be Exempt From 510(k) Requirements
- Hong Kong Proposes Regulatory Framework for Cell and Gene Therapies
- FDA- Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry
- EU-China Regulatory Dialogue on Pharmaceuticals
- FDA- Submitting Manufacturing Facility Information: Final FDA Guidance
- EMA Updates Q&A on MDR, IVDR
- FDA Revises Guidance on Postmarketing Studies to Reflect ARIA System, SUPPORT Act